Clinical Trial Update: Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) in treatment-naive patients with chronic hepatitis C genotypes 6-9 among Asian…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Pacific Health Foundation | Conditions: Chronic Hepatitis C, Asian Americans | Phase 4 | Status: COMPLETED